We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$71.3B
1-Year Est. Return
56.8%
This Fund
S&P 500
This Quarter
Est. Return
+24.89%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,007.9%
AUM
$71.3B
AUM Growth
+$6.48B
(+10%)
Cap. Flow
-$2.43B
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
29.48%
Holding
1,130
New
174
Increased
291
Reduced
392
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$353M |
| 2 |
Marvell Technology
MRVL
|
+$150M |
| 3 |
Spyre Therapeutics
SYRE
|
+$126M |
| 4 |
BridgeBio Pharma
BBIO
|
+$116M |
| 5 |
Dover
DOV
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$713M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$355M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$289M |
| 4 |
Royalty Pharma
RPRX
|
+$259M |
| 5 |
Eli Lilly
LLY
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.29% |
| 2 | Healthcare | 14.03% |
| 3 | Financials | 12.39% |
| 4 | Industrials | 8.94% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Corpay
CPAY
$26.7B
| $19.4M | 0.03% |
58,258
-4,200
| -7% | -$1.39M |
|
|
TMHC
502
DELISTED
Taylor Morrison
TMHC
| $19.4M | 0.03% |
+270,503
| New | +$17.2M |
|
503
Invitation Homes
INVH
$16.6B
| $19.4M | 0.03% |
642,100
-398,435
| -38% | -$11.3M |
|
504
Descartes Systems
DSGX
$6.29B
| $19.4M | 0.03% |
280,000
+260,000
| +1,300% | +$18.6M |
|
505
Monopar Therapeutics
MNPR
$754M
| $19.4M | 0.03% |
209,195
-100,000
| -32% | -$6.19M |
|
506
Crown Castle
CCI
$32B
| $19.2M | 0.03% |
253,960
-136,200
| -35% | -$12M |
|
507
First Industrial Realty Trust
FR
$8.08B
| $19M | 0.03% |
309,926
+264,926
| +589% | +$16.4M |
|
508
Otter Tail
OTTR
$3.76B
| $18.9M | 0.03% |
210,546
-131,454
| -38% | -$11.6M |
|
|
EVOX
509
Evolution Global Acquisition Corp
EVOX
| $18.9M | 0.03% |
1,890,000
| – | – |
|
510
KeyCorp
KEY
$23.2B
| $18.9M | 0.03% |
821,469
-14,600
| -2% | -$318K |
|
511
Edgewise Therapeutics
EWTX
$4.71B
| $18.8M | 0.03% |
+462,000
| New | +$15.9M |
|
|
HCIC
512
Hennessy Capital Investment Corp
HCIC
| $18.8M | 0.03% |
1,890,000
| – | – |
|
513
NewAmsterdam Pharma
NAMS
$2.72B
| $18.6M | 0.03% |
550,000
-556,631
| -50% | -$18.3M |
|
514
Omnicom Group
OMC
$21.5B
| $18.5M | 0.03% |
253,983
-27,900
| -10% | -$2.1M |
|
|
SKYT
515
DELISTED
SkyWater Technology
SKYT
| $18.5M | 0.03% |
+530,829
| New | +$18.2M |
|
516
Steris
STE
$21B
| $18.4M | 0.03% |
87,386
-100
| -0.1% | -$21.4K |
|
517
VeriSign
VRSN
$25.9B
| $18.4M | 0.03% |
73,040
-600
| -0.8% | -$167K |
|
|
SAAQ
518
Space Asset Acquisition Corp
SAAQ
$316M
| $18.4M | 0.03% |
1,800,000
| – | – |
|
|
SVIV
519
Spring Valley Acquisition Corp IV
SVIV
$312M
| $18.3M | 0.03% |
1,800,000
| – | – |
|
|
VIA
520
Via Transportation Inc
VIA
$2.12B
| $18.3M | 0.03% |
1,010,101
+183,678
| +22% | +$2.88M |
|
|
HVMC
521
Highview Merger Corp
HVMC
$301M
| $18.3M | 0.03% |
1,800,000
| – | – |
|
522
DTE Energy
DTE
$28.3B
| $18.3M | 0.03% |
+119,912
| New | +$17.5M |
|
|
OTGA
523
OTG Acquisition Corp I
OTGA
$302M
| $18.3M | 0.03% |
1,800,000
| – | – |
|
|
MTAL
524
Metals Acquisition Corp II
MTAL
$313M
| $18.3M | 0.03% |
+1,800,000
| New | +$18.2M |
|
|
IPXG
525
Inflection Point Acquisition Corp. VII Class A Ordinary Shares
IPXG
$315M
| $18.3M | 0.03% |
1,800,000
| – | – |
|
Similar funds
Adage Capital Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Adage Capital Partners held 1,130 positions worth $71.3B, up 10% from $64.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Adage Capital Partners withdrew a net $2.43B in Q2 2026, closing 128 positions and reducing 392 holdings. Its most notable exit was Centessa Pharmaceuticals, an estimated $355M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Marvell Technology worth $222M.
- Adage Capital Partners's largest Q2 2026 buy was Marvell Technology: 745,800 shares worth $222M.
- Adage Capital Partners added most to Devon Energy in Q2 2026, an estimated $353M increase.
- Adage Capital Partners's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $713M.
- Adage Capital Partners fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $355M.
- Adage Capital Partners's ten largest holdings make up 29% of its $71.3B portfolio in Q2 2026.
- Adage Capital Partners opened 174 new positions and closed 128 in Q2 2026.
- Adage Capital Partners's portfolio value rose 10% quarter-over-quarter to $71.3B.
Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.